Low Cardiac index is associated with incident dementia and alzheimer disease: The framingham heart study

Circulation

Volumn 131, Issue 15, 2015, Pages 1333-1339

  Jefferson, Angela L ^a   Beiser, Alexa S ^b,c,d   Himali, Jayandra J ^b,c   Seshadri, Sudha ^b,c   O'Donnell, Christopher J ^c   Manning, Warren J ^e   Wolf, Philip A ^b,c   Au, Rhoda ^b,c   Benjamin, Emelia J ^b,c,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer disease; Blood circulation; Brain; Cardiac output; Dementia; Hemodynamics

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MAGNETIC RESONANCE; CEREBROVASCULAR ACCIDENT; COMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INDEX; HEART OUTPUT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC CIRCULATION; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; COMPLICATION; FORWARD HEART FAILURE; INCIDENCE; MASSACHUSETTS; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CARDIAC OUTPUT, LOW; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; RISK FACTORS;

EID: 84929305910     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.012438     Document Type: Article

References (47)

1. Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging. 2007;28:477-483. doi: 10.1016/j.neurobiolaging.2006.01.001.
2. Jefferson AL, Himali JJ, Beiser AS, Au R, Massaro JM, Seshadri S, Gona P, Salton CJ, DeCarli C, O'Donnell CJ, Benjamin EJ, Wolf PA, Manning WJ. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation. 2010;122:690-697. doi: 10.1161/CIRCULATIONAHA.109.905091.
3. Jefferson AL, Tate DF, Poppas A, Brickman AM, Paul RH, Gunstad J, Cohen RA. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc. 2007;55:1044-1048. doi: 10.1111/j.1532-5415.2007.01226.x.
4. Jefferson AL, Holland CM, Tate DF, Csapo I, Poppas A, Cohen RA, Guttmann CR. Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output. Neurobiol Aging. 2011;32:133-139. doi: 10.1016/j.neurobiolaging.2009.01.011.
5. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001;64:575-611.
6. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62:1556-1560. doi: 10.1001/archneur.62.10.1556.
7. Borenstein AR, Wu Y, Mortimer JA, Schellenberg GD, McCormick WC, Bowen JD, McCurry S, Larson EB. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging. 2005;26:325-334. doi: 10.1016/j.neurobiolaging.2004.04.010.
8. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166:1003-1008. doi: 10.1001/archinte.166.9.1003.
9. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22:312-318.
10. Jaffer FA, O'Donnell CJ, Larson MG, Chan SK, Kissinger KV, Kupka MJ, Salton C, Botnar RM, Levy D, Manning WJ. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2002;22:849-854.
11. Salton CJ, Chuang ML, O'Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, Edelman RR, Levy D, Manning WJ. Gender differences and normal left ventricular anatomy in an adult population free of hypertension: a cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol. 2002;39:1055-1060.
12. Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, Douglas PS, Manning WJ. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol. 2000;35:477-484.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
14. Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB. Lifetime risk of dementia and Alzheimer's disease: the impact of mortality on risk estimates in the Framingham study. Neurology. 1997;49:1498-1504.
15. Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham study: the Practical Incidence Estimators (PIE) macro. Stat Med. 2000;19:1495-1522.
16. American Psychological Association Diagnostic & Statistical Manual- IV. Washington, DC: American Psychiatric Association; 1994.
17. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull. 1988;24:637-639.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
19. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 34. Bethesda, MD: National Institutes of Health; 1987. Publication No. 87-2703.
20. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-548.
21. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke. 2004;35:1857-1861. doi: 10.1161/01.STR.0000135226.53499.85.
22. Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, D'Agostino RB, DeCarli C. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology. 2004;63:1591-1599.
23. Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA. APOE, vascular pathology, and the AD brain. Neurology. 2005;65:259-265. doi: 10.1212/01.wnl.0000168863.49053.4d.
24. Givertz MM, Colucci WS, LeJemtel TH, Gottlieb SS, Hare JM, Slawsky MT, Leier CV, Loh E, Nicklas JM, Lewis BE. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation. 2000;101:2922-2927.
25. Pica S, Ghio S, Tonti G, Camporotondo R, Turco A, Pazzano AS, Scelsi L, Raineri C, Oltrona Visconti L. Analyses of longitudinal and of transverse right ventricular function provide different clinical information in patients with pulmonary hypertension. Ultrasound Med Biol. 2014;40:1096-1103. doi: 10.1016/j.ultrasmedbio.2013.12.005.
26. Lipsitz LA, Mukai S, Hamner J, Gagnon M, Babikian V. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke. 2000;31:1897-1903.
27. Oudegeest-Sander MH, van Beek AH, Abbink K, Olde Rikkert MG, Hopman MT, Claassen JA. Assessment of dynamic cerebral autoregulation and cerebrovascular CO2 reactivity in ageing by measurements of cerebral blood flow and cortical oxygenation. Exp Physiol. 2014;99:586-598. doi: 10.1113/expphysiol.2013.076455.
28. Massaro AR, Dutra AP, Almeida DR, Diniz RV, Malheiros SM. Transcranial Doppler assessment of cerebral blood flow: effect of cardiac transplantation. Neurology. 2006;66:124-126. doi: 10.1212/01.wnl.0000191397.57244.91.
29. Fraser KS, Heckman GA, McKelvie RS, Harkness K, Middleton LE, Hughson RL. Cerebral hypoperfusion is exaggerated with an upright posture in heart failure: impact of depressed cardiac output. JACC Heart Fail. 2015;3:168-175. doi: 10.1016/j.jchf.2014.07.017.
30. Wanless RB, Anand IS, Gurden J, Harris P, Poole-Wilson PA. Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther. 1987;243:1101-1106.
31. Tranmer BI, Keller TS, Kindt GW, Archer D. Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. J Neurosurg. 1992;77:253-259. doi: 10.3171/jns.1992.77.2.0253.
32. Marques F, Sousa JC, Sousa N, Palha JA. Blood-brain-barriers in aging and in Alzheimer's disease. Mol Neurodegener. 2013;8:38. doi: 10.1186/1750-1326-8-38.
33. Fonck E, Feigl GG, Fasel J, Sage D, Unser M, Rüfenacht DA, Stergiopulos N. Effect of aging on elastin functionality in human cerebral arteries. Stroke. 2009;40:2552-2556. doi: 10.1161/STROKEAHA.108.528091.
34. Flück D, Beaudin AE, Steinback CD, Kumarpillai G, Shobha N, McCreary CR, Peca S, Smith EE, Poulin MJ. Effects of aging on the association between cerebrovascular responses to visual stimulation, hypercapnia and arterial stiffness. Front Physiol. 2014;5:49. doi: 10.3389/fphys.2014.00049.
35. Pluta R. The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury: a model of early Alzheimer's disease. Ann N Y Acad Sci. 2000;903:324-334.
36. Aliev G, Smith MA, de la Torre JC, Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 2004;4:649-663. doi: 10.1016/j.mito.2004.07.018.
37. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489-1499. doi: 10.1172/JCI10498.
38. Weller RO. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol. 1998;57:885-894.
39. Weller RO, Massey A, Kuo YM, Roher AE. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann N Y Acad Sci. 2000;903:110-117.
40. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813-817.
41. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222. doi: 10.1056/NEJMoa022066.
42. Rossi R, Geroldi C, Bresciani L, Testa C, Binetti G, Zanetti O, Frisoni GB. Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment. Dement Geriatr Cogn Disord. 2007;23:175-183. doi: 10.1159/000098543.
43. Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, Delmaire C, Leys D, Pasquier F. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke. 2007;38:2924-2930. doi: 10.1161/STROKEAHA.107.488403.
44. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
45. Kass DA. Age-related changes in ventricular-arterial coupling: pathophysiologic implications. Heart Fail Rev. 2002;7:51-62.
46. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65:545-551. doi: 10.1212/01.wnl.0000172914.08967.dc.
47. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269. doi: 10.1016/j.jalz.2011.03.005.